PGA resoquick™

Metabolisation of the PGA suture within the tissue occurs by the uptake of water, thus reversing the synthesis. The monomeric glycolic acid is split enzymatically into CO₂ and H₂O by the normal metabolism.

Suture material containing 10% lactide as copolymerisate differs only slightly in its physical and physiological properties from pure PGA sutures. The fine, precision-braided filaments guarantee a very high tensile strength as well as great suppleness. The special resolactone coating thinly covers the fibre bundles for specific reduction of surface friction.

PGA Resoquick™ is indicated for use in general soft tissue approximation, including ophthalmic (e.g. conjunctiva) procedures, but not in cardiovascular or neurological procedures.

Absorbable suture approximates the tissue during the healing phase and progressively loses its tensile strength and breaking load. After only seven days PGA Resoquick™ has already lost 50% of its original breaking load. After 14 days the breaking load is lost completely.